Therapeutic value of immune cell therapy based on T memory stem cells and central memory T cells for hematological malignancies / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 71-73, 2017.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-505734
Biblioteca responsável:
WPRO
ABSTRACT
In recent years,cellular immune therapy represented by antigen-chimeric receptor T cells (CAR-T) has made a great breakthrough in the treatment of hematological malignancies.T memory stem cells (TSCM) and central memory T cells (TCM) can be used as most powerful carrier for T cell immunotherapy,however,how to regulate their differentiation in vitro and in vivo as well as how to construct a strong treatment system while without potential side effect become quite interesting.This article summarized the studies from the 58th America Society of Hematology Annual Meeting regarding to values and associated research progress about TsCM and TCM in hematological malignancies.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of Leukemia & Lymphoma
Ano de publicação:
2017
Tipo de documento:
Artigo